⚖ SoapBox law
CasesDocketsStatutesRegulationsJudgesLawyersFile a complaintOversightDataLibrary

Cases

Search U.S. court opinions (CourtListener / Free Law Project), or resolve a reporter citation to its case via the Caselaw Access Project. Facts only — name, court, date, status, citation count. Never a holding-summary.

4 opinions for “Securities and Exchange Commission v. Salix Pharmaceuticals, Ltd.”

Court of Appeals for the Federal Circuit · 2019-02-08 · Published · cited 2× · 916 F.3d 975
O'Malley, Circuit Judge. ORDER At issue are three motions to disqualify Katten Muchin Rosenman LLP as counsel for Mylan Pharmaceuticals Inc. ("Mylan") in three appeals before this court. Valeant Pharmaceuticals International, Inc. ("Valeant-CA") and Salix Pharmaceuticals, Inc. ("Salix") move to disqualify in Valeant Pharmaceuticals
District Court, N.D. Illinois · 2003-05-19 · Published · cited 20× · 262 F. Supp. 2d 937; 2003 U.S. Dist. LEXIS 8513; 2003 WL 21183390
262 F.Supp.2d 937 (2003) Thomas JOHNSON, Plaintiff, v. TELLABS, INC., Michael J. Birck, Richard C. Notebaert, John Vaughn, Robert W. Pullen, Joan E. Ryan, Brian Jackman, J. Thomas Gruenwald, Kolher, William F. Souders Catherine Kozik, Defendants. No. 02 C 4356. United States District Court, N.D. Illinois, Eastern Division. May 19, 2003. ST. EVE, District Judge.
Texas Court of Appeals, 5th District (Dallas) · 2015-05-29 · Published · cited 0×
ACCEPTED 05-15-00279-CR FIFTH COURT OF APPEALS DALLAS, TEXAS 5/28/2015 4:43:10 PM
Texas Court of Appeals, 5th District (Dallas) · 2015-05-28 · Published · cited 0×
ACCEPTED 05-15-00279-CR FIFTH COURT OF APPEALS DALLAS, TEXAS 5/28/2015 4:43:10 PM